Table. Characteristics of Study Population by Duration of Follow-up From First Dose of BNT162b2 COVID-19 Vaccine.
| Characteristic | Time from first dose, No. (%) | |
|---|---|---|
| 1-12 d (n = 503 875) | 13-24 d (n = 351 897) | |
| Age, mean (SD), y | 59.7 (14.7) | 61.7 (14.4) |
| Sex | ||
| Men | 239 647 (47.8) | 170 792 (48.8) |
| Women | 264 228 (52.4) | 180 105 (51.2) |
| BMI, mean (SD) | 27.49 (5.00) | 27.38 (5.04) |
| SES (IQR)a | 7 (5-8) | 7 (5-8) |
| Residential community | ||
| Ultraorthodox Jewish | 13 936 (2.8) | 9403 (2.7) |
| Arabic | 13 084 (2.6) | 7782 (2.2) |
| Comorbidities | ||
| Diabetes | 86 161 (17.1) | 67 662 (19.2) |
| Cardiovascular diseases | 57 057 (11.3) | 46 235 (13.1) |
| Hypertension | 186 047 (36.9) | 144 296 (41.0) |
| Cancer | 80 496 (16.0) | 64 861 (18.4) |
| Immunosuppression | 21 911 (4.3) | 16 571 (4.7) |
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); IQR, interquartile range; SES, socioeconomic status.
a
Residential area SES is measured on a scale from 1 (lowest) to 10.